CAPOXIRI+Bevacizumab

· Chugai Pharmaceutical

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAPOXIRI+Bevacizumab, covering 2019-10-31 to 2019-10-31. Get the full timeline:

Most recent: Clinical Trial Update: CAPOXIRI+Bevacizumab vs. FOLFOXIRI+Bevacizumab for mCRC [Phase 2]